kff 2025 employer health benefits survey glp-1 coverage for obesity treatment in 13 US states' Medicaid programs 2024 Employer Health Benefits Survey

Research Applications Lipid Metabolism & Fat Oxidation Methionine, Choline, and Inositol act synergistically as lipotropic agents enhancing the transport and metabolism of fats from the liver

Never Share an OZEMPIC Pen Between Patients Advise patients that they must never share an OZEMPIC pen with another person, even if the needle is changed, because doing so carries a risk for transmission of blood-borne pathogens [see Warnings and Precautions (5.4)]

One of the biggest challenges of addiction medicine is that patients often dont want to take the treatments that are available because they have negative side effects or may continue a dependency. GLP-1s have side effects, too

Abnormal hunger and weight gain are symptoms of underlying metabolic dysfunction, not lack of willpoweroften exacerbated by early and repeated dieting

Not a typical outcome, not a guarantee, and not something you can access today